|
|
|
|
|
|
Dear Friends,
The February issue of Gems has the answers to many of your questions! Discover insights on whether type 2 diabetes is a significant predictor of MACE, the impact of Ozempic on kidney disease progression in diabetes, and the role of a balanced diet in reducing diabetes risk. Don’t miss out on these and more!
We’re thrilled to share the latest findings from the SYMMETRY study on Efruxifermin, which has demonstrated the potential to reverse liver scarring in patients with cirrhosis caused by MASH. This breakthrough could bring new hope to many.
In this month’s Gems Picture of the Month, read about Theodore Ryder, the last survivor among the first twelve people with diabetes treated with insulin - a remarkable story of resilience and medical progress.
Looking for something new to try in the kitchen? Check out our Lemon Basil Chickpea Fritters Recipe and let us know how it turned out!
Afrezza, the inhaled insulin, is set to be introduced in the Indian market, and Dr. Jothydev explains its specifics in GEMS Video of the Month.
The INHALE Studies have explored its benefits, including:
- . Faster onset of action, mimicking physiological insulin response more closely
- . Convenient and needle-free administration, improving patient adherence
- . Reduced risk of post-meal hypoglycemia
Lastly, we wish all our readers a Happy Valentine’s Day!
To visit our previous issues, click here
Thanking you once again for the comments and suggestions. If in case you are not interested in receiving this free monthly scientific newsletter, kindly reply with "delete gems" in the subject line to info@jothydev.net
Regards
JDC Diabetes Gems Team
Jothydev's Diabetes and Research Centres
Trivandrum, Attingal and Kochi, Kerala, INDIA
+91 9846040055, +91 9562040055
, +91 9746366655
http://www.jothydev.net
We’re thrilled to share the latest findings from the SYMMETRY study on Efruxifermin, which has demonstrated the potential to reverse liver scarring in patients with cirrhosis caused by MASH. This breakthrough could bring new hope to many. In this month’s Gems Picture of the Month, read about Theodore Ryder, the last survivor among the first twelve people with diabetes treated with insulin - a remarkable story of resilience and medical progress. Looking for something new to try in the kitchen? Check out our Lemon Basil Chickpea Fritters Recipe and let us know how it turned out! Afrezza, the inhaled insulin, is set to be introduced in the Indian market, and Dr. Jothydev explains its specifics in GEMS Video of the Month. The INHALE Studies have explored its benefits, including:
- . Faster onset of action, mimicking physiological insulin response more closely
- . Convenient and needle-free administration, improving patient adherence
- . Reduced risk of post-meal hypoglycemia
Thanking you once again for the comments and suggestions. If in case you are not interested in receiving this free monthly scientific newsletter, kindly reply with "delete gems" in the subject line to info@jothydev.net
Regards
JDC Diabetes Gems Team
Jothydev's Diabetes and Research Centres
Trivandrum, Attingal and Kochi, Kerala, INDIA
+91 9846040055, +91 9562040055 ,+91 9746366655
http://www.jothydev.net
Gems picture of the month
Ryder was a person with type 1 diabetes, but no ordinary insulin user. At the age of four, he developed symptoms of diabetes..........
Gems picture of the month
Ryder was a person with type 1 diabetes, but no ordinary insulin user. At the age of four, he developed symptoms of diabetes..........
Type 2 diabetes infers increased risk for MACE in distinct atherosclerotic stages
It is well-established that atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality......... READ MORE
FDA approves Ozempic for reducing the risk of worsening kidney disease in type 2 diabetes – The FLOW trial
Chronic kidney disease (CKD) is a common complication of type 2 diabetes, with approximately 40% of people with type 2 diabetes also......... READ MORE
Lower risk of nephrolithiasis is tied to SGLT2 inhibitors vs. DPP4 inhibitors
People with diabetes have an increased risk of developing kidney stones, often termed nephrolithiasis. A recent research......... READ MORE
Peripheral atherosclerosis positively correlates with positive islet cell cytoplasmic antibody and long-term use of lipid-lowering medications in autoimmune diabetes
A cross-sectional study published in the ‘Journal of Diabetes Research’ determined the association of systemic inflammation, diabetic.......... READ MORE
Association of Diabetic Foot Ulcers and Occupational shoes among industrial workers
Inappropriate and poorly fitted footwear is a frequent contributor to diabetic foot ulcers (DFU). It is well-documented that people with diabetes are......... READ MORE
Balanced diets are linked to a lower risk of type 2 diabetes than plant-based diets
Human health benefits from plant-based diets, while their use is limited by certain dietary deficiencies. In a recent research published......... READ MORE
Drug Update
Akero Therapeutics recently reported promising findings from a placebo-controlled study showing its drug efruxifermin reversed.......... READ MORE
Recipe of the Month
Lemon Basil Chickpea Fritters Recipe
In a large bowl, stir together chickpeas, lemon juice, flour and salt. Mash with potato masher or fork until a thick paste.........
READ MORE
JDC Updates
Dr. Jothydev Kesavadev has released an informative video on inhaled insulin, now available on his official Facebook page. In the video, Dr. Kesavadev discusses........ READ MORE
The Newsletter team:
Chief Editor : Dr.Jothydev KesavadevManaging Editor : Sunitha Jothydev
Editor : Dr.Arun Shankar
Scientific Editor : Gopika Krishnan (Research Head, JDC Centres)
Sub Editors : Sree Lekshmi R, Anjana Basanth, Geethu Sanal
Webpage Editor : Deepu J S
Founder Editor : Neethu Annie Ajai
For enquiries info@jothydev.net.
Please visit: jothydev.net | research.jothydev.com | diabscreenkerala.net | jothydev.com/newsletter